Status:
COMPLETED
Information About a Doctor or a Possibility of Choosing Doctor's Gender and Attendance to Screening Colonoscopy
Lead Sponsor:
Maria Sklodowska-Curie National Research Institute of Oncology
Conditions:
Colorectal Cancer
Screening
Eligibility:
All Genders
55-64 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of the study is to investigate whether the information about a doctor or possibility to choose doctor's gender included in invitation letter is associated with attendance rate to screening...
Detailed Description
Study is performed as a part of NordICC (Clinical trials NCT 00883792) trial, which is intended to investigate the effect of screening colonoscopy on colorectal cancer incidence and mortality. NordICC...
Eligibility Criteria
Inclusion
- Individuals 55-64 years of age randomized to the screening arm of the NordICC trial in Poland
Exclusion
- previous open colorectal surgery
- need for long term attention and nursing services (somatic or psychosocial reasons, mental retardation)
- ongoing cytotoxic treatment or radiotherapy for malignant disease
- severe chronic cardiac or pulmonary disease (NYHA III and IV)
- lifelong anticoagulant treatment
- coronary or cerebrovascular incident requiring hospitalization during the last three months
- residence abroad
- return of unopened letter of invitation and/or reminder, or message of death of the subject (not updated in Population Registry)
- failure to provide written informed consent
- screening colonoscopy within 10 years
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
5100 Patients enrolled
Trial Details
Trial ID
NCT01182922
Start Date
August 1 2010
End Date
August 1 2011
Last Update
November 18 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,
Warsaw, Poland, 02-781